|
|
Volumn 46, Issue 3, 2006, Pages 411-415
|
|
New drugs: lubiprostone, ranolazine, and anidulafungin.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANIDULAFUNGIN;
ANTIFUNGAL AGENT;
CALCIUM CHANNEL STIMULATING AGENT;
CYCLOPEPTIDE;
DRUG DERIVATIVE;
ENZYME INHIBITOR;
FATTY ACID;
LUBIPROSTONE;
PIPERAZINE DERIVATIVE;
PROSTAGLANDIN E1;
RANOLAZINE;
ANGINA PECTORIS;
ARTICLE;
CANDIDIASIS;
CONSTIPATION;
DRUG APPROVAL;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
LEGAL ASPECT;
UNITED STATES;
ALPROSTADIL;
ANGINA PECTORIS;
ANTIBIOTICS, ANTIFUNGAL;
CALCIUM CHANNEL AGONISTS;
CANDIDIASIS;
CONSTIPATION;
DRUG APPROVAL;
ENZYME INHIBITORS;
FATTY ACIDS;
HUMANS;
PEPTIDES, CYCLIC;
PIPERAZINES;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
MLCS;
MLOWN;
|
|
EID: 33745157540
PISSN: 15443191
EISSN: None
Source Type: Journal
DOI: 10.1331/154434506777069453 Document Type: Article |
|
Times cited : (3)
|
|
References (0)
|
